NFKB1 and diabetic kidney disease: The present study demonstrated that latent TGF-β1 was renoprotective in DKD as mice overexpressing human latent TGF-β1 were protected against diabetic kidney disease by inhibiting TGF-β/Smad3-mediated fibrosis and NF-κB/p65-driven inflammation.